The FDA has already advised the public to not eat or sell Diamond Shruumz-Brand Microdosing Chocolate Bars. Even though the agency has made all the wrong decisions in the last few years regarding Covid, most still think they are looking after the safety of the American people in this instance.
Chocolate bars and gummies marketed as “microdosing” products by Diamond Shruumz have been linked to a rising number of hospital visits, as reported by the Food and Drug Administration (FDA). The agency has issued a stern warning against consuming these products following multiple reports of severe adverse effects.
🚨 🇺🇸 BREAKING: FDA Warns Against Microdosing Mushroom Laced Chocolate Bars
These products have been linked to severe health issues, including seizures, heart irregularities, and vomiting.
Reports indicate multiple hospitalizations across several states, with symptoms such as… pic.twitter.com/YiZ2sl05C3
— Mario Nawfal (@MarioNawfal) June 11, 2024
The FDA first alerted the public on June 7 after six individuals were hospitalized upon consuming these products. Since then, the number of reported hospitalizations has increased to at least 10, with an additional two people seeking medical care without requiring hospitalization.
In response to these incidents, the FDA has advised, “Do not eat, sell, or serve Diamond Shruumz-Brand Microdosing Chocolate Bars.” The authority is actively investigating the cause of the reported illnesses and contemplating further actions, promising to update the public as more information becomes available.
Distributed nationally, the reported hospitalizations span several states including Alabama, Kentucky, Missouri, Nevada, South Carolina, and Pennsylvania, with multiple cases also emerging in Arizona and Indiana. Consumers who have ingested these chocolate bars have reported experiencing severe symptoms such as seizures, central nervous system depression (manifesting as loss of consciousness, confusion, and sleepiness), agitation, abnormal heart rates, and fluctuations in blood pressure, as well as nausea and vomiting.
Microdosing chocolate bars leads to seizures, heart issues, vomiting and hospitalizations, FDA warns https://t.co/GwBrthYUdl pic.twitter.com/ttphyeN2nu
— New York Post (@nypost) June 10, 2024
Microdosing typically involves consuming very small quantities of hallucinogenic substances to enhance creativity and elevate mood without inducing a full psychedelic experience. However, despite being marketed for microdosing, Diamond Shruumz claims that their chocolate bars and gummies do not contain psilocybin or any other controlled hallucinogens.
The company’s website asserts, “There is no presence of psilocybin, amanita or any scheduled drugs, ensuring a safe and enjoyable experience. Our treats are not only free from psychedelic substances but our carefully crafted ingredients still offer an experience.” The site describes their products as being specially blended for both pleasure and peace of mind.
More people sent to hospital as mushroom-infused ‘microdosing’ chocolate faces ongoing FDA probe https://t.co/clz1Pk3jK8
— Fox News (@FoxNews) June 17, 2024
After these serious health incidents, the investigation by the FDA and the Centers for Disease Control and Prevention is ongoing. Let’s hope there aren’t any more hurt from them, and above that, hope the FDA is going in the right direction on it all.
Major Points:
- The FDA has issued a warning against Diamond Shruumz-brand microdosing chocolate bars and gummies following multiple hospitalizations.
- Initially, six people were hospitalized, but the number has since risen to at least 10, with additional individuals seeking medical care.
- Consumers have reported severe symptoms including seizures, confusion, agitation, abnormal heart rates, and nausea after consuming the products.
- Despite being marketed as containing no psilocybin or other controlled substances, these incidents have raised serious safety concerns.
- Investigations by the FDA and the Centers for Disease Control and Prevention into the cause of these illnesses are ongoing.
Charles William III – Reprinted with permission of Whatfinger News
